UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Emerging RNA-binding roles in the TRIM family of ubiquitin ligases

Biological chemistry, 2019-11, Vol.400 (11), p.1443

2019

Volltextzugriff (PDF)

Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition

Nature communications, 2018-05, Vol.9 (1), p.1820-13, Article 1820

2018

Volltextzugriff (PDF)

Validation and classification of RNA binding proteins identified by mRNA interactome capture

RNA (Cambridge), 2021-10, Vol.27 (10), p.1173-1185

2021

Volltextzugriff (PDF)

Vault RNA1-1 riboregulates the autophagic function of p62 by binding to lysine 7 and arginine 21, both of which are critical for p62 oligomerization

RNA (Cambridge), 2022-05, Vol.28 (5), p.742-755

2022

Volltextzugriff (PDF)

Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2

Nature communications, 2023-10, Vol.14 (1), p.6345-6345, Article 6345

2023

Volltextzugriff (PDF)

Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction

Frontiers in molecular neuroscience, 2017-05, Vol.10, p.140-140

2017

Volltextzugriff (PDF)

Breaking free from the crystal lattice: Structural biology in solution to study protein degraders

Current opinion in structural biology, 2023-04, Vol.79, p.102534-102534, Article 102534

2023

Volltextzugriff (PDF)

Automated Determination of Nuclear Magnetic Resonance Chemical Shift Perturbations in Ligand Screening Experiments: The PICASSO Web Server

Journal of chemical information and modeling, 2021-12, Vol.61 (12), p.5726-5733

2021

Volltextzugriff (PDF)

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

AIDS (London), 2009-06, Vol.23 (9), p.1109-1118

2009

Volltextzugriff (PDF)

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

The New England journal of medicine, 2008-05, Vol.358 (20), p.2095-2106

2008

Volltextzugriff (PDF)

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection

AIDS (London), 2011-11, Vol.25 (18), p.2269-2278

2011

Volltextzugriff (PDF)

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants

The Journal of infectious diseases, 2017-09, Vol.216 (5), p.554-564

2017

Volltextzugriff (PDF)

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Cost effectiveness and resource allocation, 2011-05, Vol.9 (1), p.5-5

2011

Volltextzugriff (PDF)

Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study

Journal of acquired immune deficiency syndromes (1999), 2011-11, Vol.58 (3), p.253

2011

Volltextzugriff (PDF)

Initial Viral Decay to Assess the Relative Antiretroviral Potency of PI-, NNRTI- and NRTI-Sparing Regimens for First Line Therapy of HIV Infection

AIDS (London), 2011-11, Vol.25 (18), p.2269-2278

2011

Volltextzugriff (PDF)

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitorsparing regimens for initial HIV treatment

AIDS (London), 2009, Vol.23 (9), p.1109-1118

2009

Volltextzugriff (PDF)

Delayed Application of Condoms Is a Risk Factor for Human Immunodeficiency Virus Infection among Homosexual and Bisexual Men

American journal of epidemiology, 2003-02, Vol.157 (3), p.210-217

2003

Volltextzugriff (PDF)

Hey Alexa, are you HIPAA compliant?

Ophthalmology Times, 2018-08, Vol.43 (13), p.38-38

2018

Volltextzugriff (PDF)

'Hey Alexa, are you HIPAA compliant?': Virtual assistants might seem a saving grace, but don't be fooled-they have much to learn

Ophthalmology times, 2018-08, Vol.43 (13), p.38

2018

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)
magazinearticle
(1)

Sprache

Englisch
(19)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(12)
Humans
(10)
Infectious Diseases
(7)
Adult
(6)
Female
(6)
Male
(6)
Biological And Medical Sciences
(5)
Hiv
(5)
Hiv Infections - Drug Therapy
(5)
Human Viral Diseases
(5)
Medical Sciences
(5)
Proteins
(5)
Viral Diseases
(5)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(5)
Antiretroviral Therapy
(4)
Biochemistry & Molecular Biology
(4)
Immunology
(4)
Middle Aged
(4)
Benzoxazines - Adverse Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Emerging RNA-binding roles in the TRIM family of ubiquitin ligases

Molecular mechanism of influenza A NS1-mediated TRIM25 recognition and inhibition

Validation and classification of RNA binding proteins identified by mRNA interactome capture

Vault RNA1-1 riboregulates the autophagic function of p62 by binding to lysine 7 and arginine 21, both of which are critical for p62 oligomerization

Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2

Fe65-PTB2 Dimerization Mimics Fe65-APP Interaction

Breaking free from the crystal lattice: Structural biology in solution to study protein degraders

Automated Determination of Nuclear Magnetic Resonance Chemical Shift Perturbations in Ligand Screening Experiments: The PICASSO Web Server

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data

Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study

Initial Viral Decay to Assess the Relative Antiretroviral Potency of PI-, NNRTI- and NRTI-Sparing Regimens for First Line Therapy of HIV Infection

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitorsparing regimens for initial HIV treatment

Delayed Application of Condoms Is a Risk Factor for Human Immunodeficiency Virus Infection among Homosexual and Bisexual Men

Hey Alexa, are you HIPAA compliant?

'Hey Alexa, are you HIPAA compliant?': Virtual assistants might seem a saving grace, but don't be fooled-they have much to learn

Suchergebnisse filtern